Developer docs
API playgroundTry for free, no card

Search company profiles

PB Bioscience

Full company profile

uuid002hxcl

Namestring
PB Bioscience
Legal namestring
PB Bioscience Limited
Company typeenum
Private
Founded yearint
2012
Descriptiontext

PB Bioscience Limited is a Newcastle University spinout founded in 2012 by Professor Mark Birch-Machin (molecular dermatology and mitochondrial DNA specialist) and Dr Georg Lietz (nutrigenomics). The company operates at the intersection of mitochondrial health and nutritional biology, offering scientifically validated testing services to the food, drink, health, and wellness industries. Its core technology combines mitochondrial DNA (mtDNA) damage assessment via real-time PCR with whole-blood chemiluminescence assays to measure oxidative stress, positioning it as a more physiologically relevant alternative to standard cell-free antioxidant tests such as ORAC, TEAC, and FRAP.

The commercial product portfolio centres on B2B laboratory testing services — including an Antioxidant Potency Test, Cell Toxicity Test, Gene Expression Analysis, SILAC-based Quantitative Proteomics (delivered with Newcastle University's NUPPA), collaborative Antioxidant Development, and Nutritional Intervention Trials using dedicated human trial facilities. The company is also developing a consumer-facing Oxidative Stress Testing Device based on whole-blood chemiluminescence that enables individuals to assess their antioxidant status from a single drop of blood and identify personalised dietary interventions. Revenue is generated through professional services fees from industry clients and, once commercialised, hardware sales to consumers.

The company remains a small private entity (1–10 employees) with a single disclosed funding round of approximately $161,443 from Northstar Ventures in 2011. Its go-to-market leverages academic credibility, peer-reviewed publications, founder media presence, and content marketing rather than traditional sales infrastructure. Customer logos are not publicly disclosed; revenue is not reported.

Short descriptiontext

PB Bioscience is a Newcastle University spinout that provides B2B laboratory testing services — using mitochondrial DNA damage and chemiluminescence assays — to food, drink, health, and wellness companies for antioxidant product validation, and is developing a consumer-facing oxidative stress testing device.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNewcastle Upon Tyne, United Kingdom
HQ citystring
Newcastle Upon Tyne
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
antioxidant potency testing, nutrigenomics services, oxidative stress testing, mitochondrial DNA analysis, nutritional intervention trials
Industry2 codes
PRIMARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGADAA
Bioanalytical Testing (PK/ADA/NAb)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Testing Laboratories and Services541380
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Nutraceutical Testing Services
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Industry Testing Services
TypeProfessional Services
Description

Commercial laboratory testing services for food and drink companies to validate antioxidant claims, test product efficacy, and support health benefit claims with scientific evidence.

pbbioscience.co.uk
2Consumer Antioxidant Testing Device
TypeHardware Sales
Description

Consumer-facing testing device for individual antioxidant status optimization, allowing consumers to determine which antioxidants would successfully boost their cellular health.

pbbioscience.co.uk
3Nutritional Intervention Trials
TypeProfessional Services
Description

In vivo clinical testing services for approved compounds and nutritional products in healthy volunteers, including ADME determination using dedicated human intervention trial facilities.

pbbioscience.co.uk
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PB Bioscience provides laboratory testing services that use mitochondrial DNA damage as a biomarker of cellular oxidative stress to validate the potency and efficacy of antioxidant compounds and nutritional products. Its services are sold primarily to food, drink, and health and wellness industry clients to support health benefit claims, formulation development, and personalized nutrition interventions. The company is also developing a consumer-facing whole-blood chemiluminescence device for personal antioxidant status assessment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Consuming wild blueberries for 12 weeks reduced oxidative stress by up to 88%
+3 more records
Product overview1 text field

PB Bioscience offers a portfolio of B2B laboratory testing services for the food, drink, health, and wellness industries, centred on its core oxidative stress and antioxidant potency assessment technology. The core offerings include the Antioxidant Potency Test, Cell Toxicity Test, Gene Expression Analysis, Quantitative Proteomics (SILAC), Antioxidant Development, and Nutritional Intervention Trials. These services are provided to industry clients to test antioxidant capacity of products and ingredients. The company also developed a consumer-facing Oxidative Stress Testing Device based on whole-blood chemiluminescence assays. The unifying technology platform combines mitochondrial DNA damage assessment via real-time PCR with nutritional biology to deliver personalized nutrition insights.

Product and service7 records
1Antioxidant Potency Test
CategoryLaboratory testing service
Description

In vivo-style test that determines the potency of antioxidant compounds against oxidative stress inducers in an in vitro model, using mitochondrial DNA damage as a biomarker readout via real-time PCR assays. Provides superior physiological information compared to cell-free antioxidant tests (ORAC, TEAC, FRAP). Sold to food, drink, and health and wellness industry clients.

2Cell Toxicity Test
CategoryLaboratory testing service
Description

Tests the effect of compounds or combinations of compounds on cell viability in in vitro models across human and non-human cell types, using appropriate cell viability assays including those that interact with mitochondrial metabolism. Sold to industry clients developing or validating antioxidant and nutritional products.

3Gene Expression Analysis
CategoryLaboratory testing service
Description

Determines levels of mRNA transcript types using RT-PCR technology in desired cell culture models following treatment with antioxidant compounds, including RNA isolation, reverse transcription, and real-time methodology. Sold to industry clients for mechanism-of-action and efficacy studies.

4Antioxidant Development
CategoryConsulting / collaborative R&D service
Description

Collaborative development service working with companies to create improved single or optimal combinations of antioxidants for maximum synergistic value. Sold to health and wellness companies for formulation development.

5Quantitative Proteomics (SILAC)
CategoryLaboratory testing service
Description

Mass spectrometry-based quantitative proteomics using Stable Isotope Labelling with Amino Acids in Cell Culture to study cell signalling, post-translation modifications, protein-protein interactions, and secretomics following antioxidant treatment. Provided in collaboration with Newcastle University Protein and Proteome Analysis (NUPPA). Sold to industry clients and academic collaborators.

6Nutritional Intervention Trials
CategoryClinical trial service
Description

In vivo testing of approved compounds and nutritional products in healthy volunteers, including ADME determination, using dedicated human intervention trial facilities. Sold to industry clients seeking clinical evidence for nutritional products.

7Oxidative Stress Testing Device
CategoryConsumer diagnostic hardware
Description

Sophisticated consumer-facing testing device based on whole-blood chemiluminescence assays that quantitatively detects oxidative stress from a single drop of blood, enabling consumers to assess their antioxidant status and determine which dietary antioxidants would optimize their cellular health. Targeted at individual consumers; under development.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2012-01-01
Description

PB Bioscience is an official Newcastle University spinout company founded by Prof. Mark Birch-Machin and Dr Georg Lietz. The company leverages university research facilities and maintains ongoing collaboration for nutrigenomics research, SILAC proteomics analysis (NUPPA), and human intervention trial facilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Personalised nutrition company using microbiome profiling to deliver dietary recommendations that modulate blood sugar. Comparable positioning and consumer testing-product adjacency.

TypeEmerging player
Description

Consumer genetic/nutrigenomics testing brand offering personalised diet and fitness recommendations. Comparable as a biomarker-based personalised nutrition product targeting overlapping consumer segments.

TypeEmerging player
Description

Consumer-focused genetic and biomarker testing company offering personal health and nutrition insights. Comparable as a direct-to-consumer testing business built around novel cellular biomarkers.

TypeBroad incumbent
Description

Large contract research organisation providing analytical and biological testing services to the life sciences industry. Overlaps with PB Bioscience in cell-based assays, gene expression analysis, and proteomics service delivery.

TypeDirect peer
Description

Consumer personalised nutrition company combining blood fat, blood sugar and gut microbiome tests with dietary recommendations. Closely comparable business model around at-home biomarker testing and personalised dietary advice.

TypeBroad incumbent
Description

Major testing, inspection and certification services provider with food and life-sciences testing capabilities. Comparable as a broad incumbent competing for the same food-and-drink brand testing spend.

TypeEmerging player
Description

Specialised life-sciences testing provider using ex vivo human skin models and proprietary assays to support cosmetic and dermatology R&D. Comparable as a niche biomarker-testing spinout commercialising academic research into B2B testing services.

TypeBroad incumbent
Description

Global leader in food, pharma and cosmetic testing services operating at scale. Comparable as a broad incumbent offering commercial laboratory testing and validation services to the same food/health-and-wellness brand customer base that PB Bioscience targets.

TypeDirect peer
Description

Direct-to-consumer personalised nutrition platform using proprietary biomarker assays (gut microbiome and gene expression) to recommend dietary interventions. Highly comparable as a personalised-nutrition and consumer-testing peer targeting the same end-user problem.

TypeEmerging player
Description

Genetic-based skin analysis and personalised skincare testing service. Comparable as a DNA-biomarker consumer testing business built on a founder's academic research, reflecting PB Bioscience's mtDNA-test commercialisation angle.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PB Bioscience

Nutraceutical Testing Servicespbbioscience.co.uk

PB Bioscience is a Newcastle University spinout that provides B2B laboratory testing services — using mitochondrial DNA damage and chemiluminescence assays — to food, drink, health, and wellness companies for antioxidant product validation, and is developing a consumer-facing oxidative stress testing device.

What PB Bioscience does

PB Bioscience Limited is a Newcastle University spinout founded in 2012 by Professor Mark Birch-Machin (molecular dermatology and mitochondrial DNA specialist) and Dr Georg Lietz (nutrigenomics). The company operates at the intersection of mitochondrial health and nutritional biology, offering scientifically validated testing services to the food, drink, health, and wellness industries. Its core technology combines mitochondrial DNA (mtDNA) damage assessment via real-time PCR with whole-blood chemiluminescence assays to measure oxidative stress, positioning it as a more physiologically relevant alternative to standard cell-free antioxidant tests such as ORAC, TEAC, and FRAP.

The commercial product portfolio centres on B2B laboratory testing services — including an Antioxidant Potency Test, Cell Toxicity Test, Gene Expression Analysis, SILAC-based Quantitative Proteomics (delivered with Newcastle University's NUPPA), collaborative Antioxidant Development, and Nutritional Intervention Trials using dedicated human trial facilities. The company is also developing a consumer-facing Oxidative Stress Testing Device based on whole-blood chemiluminescence that enables individuals to assess their antioxidant status from a single drop of blood and identify personalised dietary interventions. Revenue is generated through professional services fees from industry clients and, once commercialised, hardware sales to consumers.

The company remains a small private entity (1–10 employees) with a single disclosed funding round of approximately $161,443 from Northstar Ventures in 2011. Its go-to-market leverages academic credibility, peer-reviewed publications, founder media presence, and content marketing rather than traditional sales infrastructure. Customer logos are not publicly disclosed; revenue is not reported.

PB Bioscience firmographics

Firmographics
Name
PB Bioscience
Legal name
PB Bioscience Limited
Website
https://pbbioscience.co.uk
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
1–10 employees
Short description
PB Bioscience is a Newcastle University spinout that provides B2B laboratory testing services — using mitochondrial DNA damage and chemiluminescence assays — to food, drink, health, and wellness companies for antioxidant product validation, and is developing a consumer-facing oxidative stress testing device.
Ownership category
akta.pro rank

PB Bioscience industry classification

Industry
Product category
Nutraceutical Testing Services
NAICS
Scientific Research and Development Services (5417), Testing Laboratories and Services (541380), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGADAA
Bioanalytical Testing (PK/ADA/NAb)

Keywords

  • Antioxidant potency testing
  • Nutrigenomics services
  • Oxidative stress testing
  • Mitochondrial DNA analysis
  • Nutritional intervention trials

Where PB Bioscience is headquartered

Location

Headquarters

HQ city
Newcastle Upon Tyne
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

PB Bioscience business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Others

Revenue model

  1. Industry Testing Services: Commercial laboratory testing services for food and drink companies to validate antioxidant claims, test product efficacy, and support health benefit claims with scientific evidence.
  2. Consumer Antioxidant Testing Device: Consumer-facing testing device for individual antioxidant status optimization, allowing consumers to determine which antioxidants would successfully boost their cellular health.
  3. Nutritional Intervention Trials: In vivo clinical testing services for approved compounds and nutritional products in healthy volunteers, including ADME determination using dedicated human intervention trial facilities.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

PB Bioscience product offering

Product offering

Core offering

PB Bioscience provides laboratory testing services that use mitochondrial DNA damage as a biomarker of cellular oxidative stress to validate the potency and efficacy of antioxidant compounds and nutritional products. Its services are sold primarily to food, drink, and health and wellness industry clients to support health benefit claims, formulation development, and personalized nutrition interventions. The company is also developing a consumer-facing whole-blood chemiluminescence device for personal antioxidant status assessment.

Product overview

PB Bioscience offers a portfolio of B2B laboratory testing services for the food, drink, health, and wellness industries, centred on its core oxidative stress and antioxidant potency assessment technology. The core offerings include the Antioxidant Potency Test, Cell Toxicity Test, Gene Expression Analysis, Quantitative Proteomics (SILAC), Antioxidant Development, and Nutritional Intervention Trials. These services are provided to industry clients to test antioxidant capacity of products and ingredients. The company also developed a consumer-facing Oxidative Stress Testing Device based on whole-blood chemiluminescence assays. The unifying technology platform combines mitochondrial DNA damage assessment via real-time PCR with nutritional biology to deliver personalized nutrition insights.

Differentiator

Problem solved

Functional benefit

Products and services

  • Antioxidant Potency Test In vivo-style test that determines the potency of antioxidant compounds against oxidative stress inducers in an in vitro model, using mitochondrial DNA damage as a biomarker readout via real-time PCR assays. Provides superior physiological information compared to cell-free antioxidant tests (ORAC, TEAC, FRAP). Sold to food, drink, and health and wellness industry clients.
  • Cell Toxicity Test Tests the effect of compounds or combinations of compounds on cell viability in in vitro models across human and non-human cell types, using appropriate cell viability assays including those that interact with mitochondrial metabolism. Sold to industry clients developing or validating antioxidant and nutritional products.
  • Gene Expression Analysis Determines levels of mRNA transcript types using RT-PCR technology in desired cell culture models following treatment with antioxidant compounds, including RNA isolation, reverse transcription, and real-time methodology. Sold to industry clients for mechanism-of-action and efficacy studies.
  • Antioxidant Development Collaborative development service working with companies to create improved single or optimal combinations of antioxidants for maximum synergistic value. Sold to health and wellness companies for formulation development.
  • Quantitative Proteomics (SILAC) Mass spectrometry-based quantitative proteomics using Stable Isotope Labelling with Amino Acids in Cell Culture to study cell signalling, post-translation modifications, protein-protein interactions, and secretomics following antioxidant treatment. Provided in collaboration with Newcastle University Protein and Proteome Analysis (NUPPA). Sold to industry clients and academic collaborators.
  • Nutritional Intervention Trials In vivo testing of approved compounds and nutritional products in healthy volunteers, including ADME determination, using dedicated human intervention trial facilities. Sold to industry clients seeking clinical evidence for nutritional products.
  • Oxidative Stress Testing Device Sophisticated consumer-facing testing device based on whole-blood chemiluminescence assays that quantitatively detects oxidative stress from a single drop of blood, enabling consumers to assess their antioxidant status and determine which dietary antioxidants would optimize their cellular health. Targeted at individual consumers; under development.

Quantifiable outcome

  • Consuming wild blueberries for 12 weeks reduced oxidative stress by up to 88%
  • +3 more outcomes

Companies that use PB Bioscience

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

PB Bioscience technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

PB Bioscience partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Newcastle UniversitycoreStrategic or Co-development Partner · 1 January 2012PB Bioscience is an official Newcastle University spinout company founded by Prof. Mark Birch-Machin and Dr Georg Lietz. The company leverages university research facilities and maintains ongoing collaboration for nutrigenomics research, SILAC proteomics analysis (NUPPA), and human intervention trial facilities.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

PB Bioscience competitors and assessment

Company assessment

Emerging players

  • DayTwo: Personalised nutrition company using microbiome profiling to deliver dietary recommendations that modulate blood sugar. Comparable positioning and consumer testing-product adjacency.
  • DNAfit: Consumer genetic/nutrigenomics testing brand offering personalised diet and fitness recommendations. Comparable as a biomarker-based personalised nutrition product targeting overlapping consumer segments.
  • Orig3n: Consumer-focused genetic and biomarker testing company offering personal health and nutrition insights. Comparable as a direct-to-consumer testing business built around novel cellular biomarkers.
  • Genoskin: Specialised life-sciences testing provider using ex vivo human skin models and proprietary assays to support cosmetic and dermatology R&D. Comparable as a niche biomarker-testing spinout commercialising academic research into B2B testing services.
  • SkinDNA: Genetic-based skin analysis and personalised skincare testing service. Comparable as a DNA-biomarker consumer testing business built on a founder's academic research, reflecting PB Bioscience's mtDNA-test commercialisation angle.

Broad incumbents

  • Charles River Laboratories: Large contract research organisation providing analytical and biological testing services to the life sciences industry. Overlaps with PB Bioscience in cell-based assays, gene expression analysis, and proteomics service delivery.
  • SGS Société Générale de Surveillance: Major testing, inspection and certification services provider with food and life-sciences testing capabilities. Comparable as a broad incumbent competing for the same food-and-drink brand testing spend.
  • Eurofins Scientific: Global leader in food, pharma and cosmetic testing services operating at scale. Comparable as a broad incumbent offering commercial laboratory testing and validation services to the same food/health-and-wellness brand customer base that PB Bioscience targets.

Direct peers

  • ZOE: Consumer personalised nutrition company combining blood fat, blood sugar and gut microbiome tests with dietary recommendations. Closely comparable business model around at-home biomarker testing and personalised dietary advice.
  • Viome: Direct-to-consumer personalised nutrition platform using proprietary biomarker assays (gut microbiome and gene expression) to recommend dietary interventions. Highly comparable as a personalised-nutrition and consumer-testing peer targeting the same end-user problem.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

PB Bioscience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PB Bioscience leadership team

Management profile

Number of profiles

Profiles3 records

PB Bioscience funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PB Bioscience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PB Bioscience

What does PB Bioscience do?

PB Bioscience provides laboratory testing services that use mitochondrial DNA damage as a biomarker of cellular oxidative stress to validate the potency and efficacy of antioxidant compounds and nutritional products. Its services are sold primarily to food, drink, and health and wellness industry clients to support health benefit claims, formulation development, and personalized nutrition interventions. The company is also developing a consumer-facing whole-blood chemiluminescence device for personal antioxidant status assessment.

Is PB Bioscience a public or private company?

PB Bioscience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was PB Bioscience founded?

PB Bioscience was founded in 2012. It employs 1 to 10 people.

Where is PB Bioscience based?

PB Bioscience is headquartered in Newcastle Upon Tyne, United Kingdom, in the Europe region.

How does PB Bioscience make money?

Three revenue lines are on record. Industry Testing Services are the primary driver. The others are consumer Antioxidant Testing Device and nutritional Intervention Trials.

Who are PB Bioscience's main competitors?

Emerging players on record are DayTwo, DNAfit, Orig3n, Genoskin and SkinDNA. Broad incumbents are Charles River Laboratories, SGS Société Générale de Surveillance and Eurofins Scientific. Direct peers are ZOE and Viome.

Does PB Bioscience have an API?

No public API is recorded for PB Bioscience.

What industry is PB Bioscience in?

PB Bioscience's product category is Nutraceutical Testing Services. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR), with a secondary code of HLAGADAA, Bioanalytical Testing (PK/ADA/NAb). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales